Micha Levy

4.6k total citations · 1 hit paper
51 papers, 3.5k citations indexed

About

Micha Levy is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Micha Levy has authored 51 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pharmacology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Micha Levy's work include Inflammasome and immune disorders (11 papers), Blood disorders and treatments (8 papers) and Inflammatory mediators and NSAID effects (5 papers). Micha Levy is often cited by papers focused on Inflammasome and immune disorders (11 papers), Blood disorders and treatments (8 papers) and Inflammatory mediators and NSAID effects (5 papers). Micha Levy collaborates with scholars based in Israel, United States and Germany. Micha Levy's co-authors include Eldad Ben‐Chetrit, Ester Zylber‐Katz, M Eliakim, Yoseph Caraco, Bernd Rosenkranz, Dennis E. Drayer, Marcus M. Reidenberg, Samuel Shapiro, David W. Kaufman and L. Granit and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Micha Levy

49 papers receiving 3.2k citations

Hit Papers

Familial Mediterranean fever 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Micha Levy Israel 31 1.4k 647 556 494 461 51 3.5k
Eberhard Wieland Germany 38 1.2k 0.9× 535 0.8× 911 1.6× 359 0.7× 212 0.5× 132 4.6k
C. Michael Stein United States 36 1.0k 0.8× 925 1.4× 658 1.2× 626 1.3× 135 0.3× 68 7.0k
Uzi Gafter Israel 41 1.0k 0.7× 501 0.8× 1.2k 2.2× 210 0.4× 2.2k 4.8× 174 6.8k
Jérôme Biollaz Switzerland 41 1.2k 0.9× 131 0.2× 297 0.5× 451 0.9× 333 0.7× 155 6.1k
Victor W. Armstrong Germany 57 2.1k 1.5× 530 0.8× 2.5k 4.5× 788 1.6× 423 0.9× 239 9.8k
Christian T. Ruff United States 44 1.9k 1.4× 347 0.5× 2.6k 4.7× 587 1.2× 476 1.0× 175 14.5k
In‐Jin Jang South Korea 40 1.5k 1.1× 253 0.4× 751 1.4× 808 1.6× 100 0.2× 306 5.9k
Sabine M. J. M. Straus Netherlands 31 764 0.6× 305 0.5× 270 0.5× 241 0.5× 56 0.1× 108 3.7k
Vincent Pichette Canada 39 516 0.4× 186 0.3× 542 1.0× 356 0.7× 1.4k 3.0× 106 4.4k
Stephan Krähenbühl Switzerland 32 988 0.7× 117 0.2× 446 0.8× 236 0.5× 52 0.1× 100 3.1k

Countries citing papers authored by Micha Levy

Since Specialization
Citations

This map shows the geographic impact of Micha Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micha Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micha Levy more than expected).

Fields of papers citing papers by Micha Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micha Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micha Levy. The network helps show where Micha Levy may publish in the future.

Co-authorship network of co-authors of Micha Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Micha Levy. A scholar is included among the top collaborators of Micha Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micha Levy. Micha Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neubert, Antje, Harald Dormann, Manfred Criegee‐Rieck, et al.. (2006). Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients?. European Journal of Clinical Pharmacology. 62(11). 959–965. 32 indexed citations
2.
Kaufman, David W., Judith P. Kelly, Surapol Issaragrisil, et al.. (2005). Relative incidence of agranulocytosis and aplastic anemia. American Journal of Hematology. 81(1). 65–67. 34 indexed citations
3.
Ben‐Chetrit, Eldad, Ruth Fischel, Burkhard Hinz, & Micha Levy. (2004). The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2. Rheumatology International. 25(5). 332–335. 19 indexed citations
4.
Dormann, Harald, Manfred Criegee‐Rieck, Antje Neubert, et al.. (2003). Lack of Awareness of Community-Acquired Adverse Drug Reactions Upon Hospital Admission. Drug Safety. 26(5). 353–362. 66 indexed citations
5.
Levy, Micha, Rifaat Safadi, Ester Zylber‐Katz, L. Granit, & Yoseph Caraco. (2001). Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators. European Journal of Clinical Pharmacology. 57(6-7). 461–465. 6 indexed citations
6.
Dormann, Harald, Uta Muth‐Selbach, Sabine Krebs, et al.. (2000). Incidence and Costs of Adverse Drug Reactions During Hospitalisation. Drug Safety. 22(2). 161–169. 142 indexed citations
7.
Ben‐Chetrit, Eldad & Micha Levy. (1998). Colchicine: 1998 update. Seminars in Arthritis and Rheumatism. 28(1). 48–59. 259 indexed citations
8.
Ben‐Chetrit, Eldad & Micha Levy. (1998). Familial Mediterranean fever. The Lancet. 351(9103). 659–664. 547 indexed citations breakdown →
9.
Levy, Micha, Yoseph Caraco, & Gerd Geißlinger. (1998). Drug Acetylation in Liver Disease. Clinical Pharmacokinetics. 34(3). 219–226. 13 indexed citations
10.
Levy, Micha, et al.. (1998). Computerized surveillance of adverse drug reactions in hospital: pilot study. British Journal of Clinical Pharmacology. 45(3). 309–314. 55 indexed citations
11.
Levy, Micha. (1997). Role of Viral Infections in the Induction of Adverse Drug Reactions. Drug Safety. 16(1). 1–8. 48 indexed citations
12.
Geißlinger, Gerd, R. Böcker, & Micha Levy. (1996). High-Performance Liquid Chromatographic Analysis of Dipyrone Metabolites to Study Their Formation in Human Liver Microsomes. Pharmaceutical Research. 13(8). 1272–1275. 27 indexed citations
13.
Zylber‐Katz, Ester, Yoseph Caraco, L. Granit, & Micha Levy. (1995). Dipyrone metabolism in liver disease*. Clinical Pharmacology & Therapeutics. 58(2). 198–209. 15 indexed citations
14.
Caraco, Yoseph, Ester Zylber‐Katz, Elliot M. Berry, & Micha Levy. (1992). Significant weight reduction in obese subjects enhances carbamazepine elimination. Clinical Pharmacology & Therapeutics. 51(5). 501–506. 32 indexed citations
15.
Putterman, Chaim, Eldad Ben‐Chetrit, Yoseph Caraco, & Micha Levy. (1991). Colchicine intoxication: Clinical pharmacology, risk factors, features, and management. Seminars in Arthritis and Rheumatism. 21(3). 143–155. 111 indexed citations
16.
Ben‐Chetrit, Eldad & Micha Levy. (1991). Colchicine prophylaxis in familial Mediterranean fever: Reappraisal after 15 years. Seminars in Arthritis and Rheumatism. 20(4). 241–246. 122 indexed citations
17.
Caraco, Yoseph, Ester Zylber‐Katz, L. Granit, & Micha Levy. (1990). Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?. Biopharmaceutics & Drug Disposition. 11(7). 639–643. 8 indexed citations
18.
Ackerman, Zvi, Moshe Y. Flugelman, Yohanan Wax, Daniel Shouval, & Micha Levy. (1989). Hepatitis during measles in young adults: Possible role of antipyretic drugs. Hepatology. 10(2). 203–206. 14 indexed citations
19.
Levy, Micha. (1988). Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics. Archives of Internal Medicine. 148(2). 281–285. 78 indexed citations
20.
Levy, Micha, et al.. (1978). Testicular Function in Patients with Familial Mediterranean Fever on Long-Term Colchicine Treatment. Fertility and Sterility. 29(6). 667–668. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026